Startups

RetiSpec
RetiSpec is a Toronto-based medical AI company developing retinal imaging to detect biomarkers associated with Alzheimer’s disease and other neurodegenerative conditions. Its hyperspectral eye imaging and AI algorithms aim to predict brain amyloid burden through a non-invasive eye exam, supporting research into earlier detection and more accessible screening. The company works with clinical and research partners to validate its technology and advance commercialisation. Founded in 2016, RetiSpec’s technology is currently available for research use only; its retinal assessment is not presented as an approved routine diagnostic test.
Founded 2016

